Loading...
Keywords
Last Name
Institution

Susana Chavez-Bueno, MD

TitlePhysician
InstitutionChildren's Mercy Kansas City
DepartmentPediatrics
Address2401 Gillham Rd
Kansas City MO 64108
ORCID ORCID Icon0000-0001-8371-5463 Additional info
vCardDownload vCard
    Other Positions
    TitleProfessor of Pediatrics
    InstitutionUniversity of Missouri-Kansas City
    DepartmentPediatrics

    TitleResearch Associate Professor of Pediatrics
    InstitutionUniversity of Kansas Medical Center
    DepartmentPediatrics


    Collapse Biography 
    Collapse education and training
    National Autonomous University of Mexico, Mexico CityMD1997
    Children's Hospital of Oklahoma, Oklahoma City, OKResidency2001Pediatrics
    University of Texas Southwestern Medical Center, Dallas, TXFellowship2004Pediatric Infectious Disease
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX2005Postdoctoral Researcher
    Collapse awards and honors
    2021Diversity, Equity & Inclusion Achievement Award, Children’s Mercy Department of Pediatrics
    2013 - 2020Best Doctors Database
    2015 - 2016Best Doctors in America, Oklahoma Magazine
    2013Research Mentor Award, OUHSC Department of Pediatrics Research
    2001The Harris D. Riley, Jr. Pediatric Society’s Award, Children’s Hospital of Oklahoma

    Collapse Overview 

    Collapse Research 
    Collapse research overview
    Dr. Chavez-Bueno’s current research work focuses on the pathogenesis of E. coli sepsis in newborns. Her overall research goal is to identify novel virulence factors relevant to the pathogen’s ability to traverse the gut and invade the bloodstream causing neonatal sepsis. Her studies utilize in vitro and animal models designed to characterize the bacterial components that determine invasion and trafficking across intestinal epithelium and interact with gut specific immune regulators as potential therapeutic targets to decrease life-threatening neonatal E. coli disease.

    Dr. Chavez-Bueno is an elected member of the Society for Pediatric Research and member of the Infectious Diseases Society of America.
    Collapse research activities and funding
         (Chavez-Bueno)Jan 1, 2002 - Dec 31, 2004
    Pediatric Infectious Disease Society (PIDS) Fellowship Award
    Chemokines in RSV-Induced Airway Hyperresponsiveness
         (Chavez-Bueno)Jan 1, 2003 - Dec 31, 2003
    Clinical Research Support Individual Project Grant, Children’s Medical Center of Dallas
    Project title: Respiratory Syncytial Virus (RSV) Quantification by Real Time Polymerase Chain Reaction and Markers of Disease Severity in Children
    MI-CP146     Jan 1, 2007 - Dec 31, 2008
    MedImmune
    A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intramuscular Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Outpatient Treatment of Children with RSV Illness
    Role: Principal Investigator
    MI-CP141     Jan 1, 2007 - Dec 31, 2010
    MedImmune
    A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized with RSV Illness
    Role: Site Principal Investigator
         Jan 1, 2008 - Dec 31, 2009
    ADMA Biologics, Inc
    A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial Evaluating the Safety and Efficacy of RI-001 in Medically Immunosupressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Respiratory Tract RSV Illness
    Role: Site Principal Investigator
         Jan 1, 2008 - Dec 31, 2013
    Cubist Pharmaceuticals, Inc
    An Evaluation of the Safety, Efficacy and Pharmacokinetics of Daptomycin in Pediatric Subjects Aged Seven to Seventeen Years with Complicated Skin and Skin Structure Infections Caused by Gram-Positive Pathogens
    Role: Site Principal Investigator
         Jan 1, 2010 - Dec 31, 2011
    LaRoche Hoffmann LTD
    An Open Label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir (Tamiflu®) in the Treatment of Children 1 to 12 years of age with Influenza Infection
    Role: Site Principal Investigator
         (Chavez-Bueno)Mar 1, 2012 - Feb 28, 2013
    University of Oklahoma Health Sciences Center Vicepresident for research seed grant
    Escherichia coli K1 Invasive Infections in Neonates
    Role: Principal Investigator
    DAP-PEDBAC-11-02     (Aurelia Balan)Nov 19, 2012 - Jan 31, 2014

    A Comparative Evaluation of the Safety and Efficacy of Daptomycin versus Standard of Care in Pediatric Subjects Two-Seventeen Years of Age with Bacteremia Caused by Staphylococcus aureus
    Role: Sub-investigator
    8P20GM103447     Jul 1, 2013 - Mar 31, 2014
    Oklahoma IDeA Network for Biomedical Research Excellence (INBRE), NIH/NIGMS pilot grant award
    Escherichia coli K1 Invasive Infections in Neonates
    Role: Sub-project Principal Investigator
         (Chavez-Bueno)Jul 1, 2014 - Dec 31, 2015
    OUHSC College of Medicine Alumni Association (COMAA)
    Escherichia Coli Colonization in Women in Preterm Labor
    Role: Principal Investigator
         (Akins)Jul 9, 2014 - Aug 5, 2016
    Oklahoma IDeA Network for Biomedical Research Excellence (INBRE) Grant, NIH/NIGMS grant award
    Identification of Virulence Factors in E. coli Strains Causing Neonatal Sepsis
    Role: Project Principal Investigator
         (Chavez-Bueno)Sep 1, 2014 - Aug 30, 2016
    Oklahoma Center for the Advancement of Science and Technology (OCAST)
    Bacterial Genes Relevant to Gut Translocation and Virulence in Neonatal Escherichia coli Strains
    Role: Principal Investigator
         (Hala Chaaban)Apr 1, 2015 - Aug 1, 2016

    NCT01994993: Antibiotic Safety in Infants with Complicated Intra-abdominal Infections, SCAMP Trial
    Role: Collaborator
         (Chavez-Bueno)Feb 1, 2016 - Aug 5, 2016
    Division of Neonatal-Perinatal medicine, Department of Pediatrics, OUHSC
    Exposure to low pH Reveals Virulence Factors in Neonatal Escherichia coli Bacteremia after Oral Inoculation
    Role: Principal Investigator
         (Chavez-Bueno)Oct 1, 2017 - Sep 30, 2019
    Katharine B. Richardson Foundation, Children's Mercy Hospital
    Role of Bacterial Virulence Factors in the Pathogenesis and Host Response to Neonatal Invasive E. coli Infections
    Role: Principal Investigator
         (Chavez-Bueno)Apr 1, 2018

    Proteomic profiling of neonates with suspected sepsis
    Role: Principal Investigator
         (Chavez-Bueno)Dec 1, 2018 - May 31, 2020
    BioNexus KC-Kansas City Area Life Sciences Institute
    Effects of Probiotics on the Intestinal Microbiome and Inflammatory Response to Infection by Bacteremia-Producing Escherichia coli
    Role: Principal Investigator
         (Chavez-Bueno)Oct 1, 2019 - Jun 30, 2022
    Marion Merrell Dow Award, , Children's Mercy Hospital
    Single Immunoglobulin Interleukin-l Related Receptor (SIGIRR) and Escherichia coli Interactions in the Neonatal Gut
    Role: Principal Investigator
         (Aashay Patel)Jan 22, 2020 - May 1, 2023
    UMKC - School of Medicine Sarah Morrison Student Research Award
    Escherichia coli Siderophore Receptor IutA as a Virulence Factor in Neonatal Sepsis
    Role: Mentor
         (Adnan Islam)Jan 22, 2020 - May 1, 2023
    Sarah Morrison Student Research Award
    Role of rfaZ in Pathogenesis of Escherichia coli Neonatal Sepsis
    Role: Mentor
         (Alain Cuna)Aug 1, 2020 - Jul 31, 2025
    NIH K08 Award (NIDDKD)
    Gene-environment interactions in necrotizing enterocolitis: the impact of SIGIRR mutation and gut microbiota on intestinal TLR hyperactivity
    Role: Co-Investigator
         (Venkatesh Sampath)Dec 1, 2020

    Genetic Susceptibility to Neonatal Diseases Repository
    Role: Co-Investigator
         (Chavez-Bueno)Jun 1, 2021 - Jun 30, 2022
    CMRI Innovator Incubator Award
    “Prenatal Lactoferrin for Newborn Health”
    Role Description: To study the administration of lactoferrin to pregnant animals to prevent neonatal E. coli infection.
    Role: Principal Investigator
         (Chavez-Bueno)Jul 1, 2022 - Dec 31, 2023
    Children’s Mercy Research Partners Award
    “Lactoferrin in Pregnancy for Newborn Health”
    Role Description: To develop a lactoferrin formulation to be used during pregnancy to prevent neonatal E. coli infection
    Role: Principal Investigator
         (Chavez-Bueno)Oct 1, 2023 - Sep 30, 2025
    Katharine B. Richardson (KBR) Award
    Prenatal Lactoferrin to Mitigate Escherichia coli-induced Preterm Delivery and Neonatal Sepsis
    Role Description: To determine the role of maternal lactoferrin administration on ameliorating E. coli-induced preterm delivery and neonatal invasive infection
    Role: Principal Investigator

    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Arredondo-Alonso S, Blundell-Hunter G, Fu Z, Gladstone RA, Fillol-Salom A, Loraine J, Cloutman-Green E, Johnsen PJ, Samuelsen ?, P?ntinen AK, Cl?on F, Chavez-Bueno S, De la Cruz MA, Ares MA, Vongsouvath M, Chmielarczyk A, Horner C, Klein N, McNally A, Reis JN, Penad?s JR, Thomson NR, Corander J, Taylor PW, McCarthy AJ. Evolutionary and functional history of the Escherichia coli K1 capsule. Nat Commun. 2023 06 15; 14(1):3294. PMID: 37322051.
      View in: PubMed
    2. Cuna A, Nsumu M, Menden HL, Chavez-Bueno S, Sampath V. The Detrimental Effects of Peripartum Antibiotics on Gut Proliferation and Formula Feeding Injury in Neonatal Mice Are Alleviated with Lactobacillus rhamnosus GG. Microorganisms. 2023 Jun 01; 11(6). PMID: 37374984.
      View in: PubMed
    3. Islam A, Wheatley JL, Chavez-Bueno S. Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates. J Vis Exp. 2023 02 17; (192). PMID: 36876937.
      View in: PubMed
    4. Rao K, Cuna A, Chavez-Bueno S, Menden H, Yu W, Ahmed I, Srinivasan P, Umar S, Sampath V. Effect of Various Preterm Infant Milk Formulas on NEC-Like Gut Injury in Mice. Front Pediatr. 2022; 10:902798. PMID: 35874567.
      View in: PubMed
    5. Williams M, Jones AB, Maxedon AL, Tabakh JE, McCloskey CB, Bard DE, Heruth DP, Chavez-Bueno S. Whole-genome sequencing-based phylogeny, antibiotic resistance, and invasive phenotype of Escherichia coli strains colonizing the cervix of women in preterm labor. BMC Microbiol. 2021 12 03; 21(1):330. PMID: 34861816.
      View in: PubMed
    6. Cuna A, Yu W, Menden HL, Feng L, Srinivasan P, Chavez-Bueno S, Ahmed I, Umar S, Sampath V. NEC-like intestinal injury is ameliorated by Lactobacillus rhamnosus GG in parallel with SIGIRR and A20 induction in neonatal mice. Pediatr Res. 2020 10; 88(4):546-555. PMID: 32053825.
      View in: PubMed
    7. Cole BK, Ilikj M, McCloskey CB, Chavez-Bueno S. Antibiotic resistance and molecular characterization of bacteremia Escherichia coli isolates from newborns in the United States. PLoS One. 2019; 14(7):e0219352. PMID: 31276562.
      View in: PubMed
    8. Rodriguez-Fernandez R, Tapia LI, Yang CF, Torres JP, Chavez-Bueno S, Garcia C, Jaramillo LM, Moore-Clingenpeel M, Jafri HS, Peeples ME, Piedra PA, Ramilo O, Mejias A. Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis. J Infect Dis. 2017 12 27; 217(1):24-34. PMID: 29045741.
      View in: PubMed
    9. Cole BK, Scott E, Ilikj M, Bard D, Akins DR, Dyer DW, Chavez-Bueno S. Route of infection alters virulence of neonatal septicemia Escherichia coli clinical isolates. PLoS One. 2017; 12(12):e0189032. PMID: 29236742.
      View in: PubMed
    10. Ugas MB, Carroll T, Kovar L, Chavez-Bueno S. Salmonella Typhi-Induced Septic Shock and Acute Respiratory Distress Syndrome in a Previously Healthy Teenage Patient Treated With High-Dose Dexamethasone. J Investig Med High Impact Case Rep. 2016 Apr-Jun; 4(2):2324709616652642. PMID: 27294165.
      View in: PubMed
    11. Williams M, Maxedon A, McCloskey C, Bard D, Chavez-Bueno S;. Prevalence of Escherichia coli Cervical Colonization in Women in Preterm Labor. Obstetrics & Gynecology. 2016; 127:70S.
      View Publication
    12. Benefield EC, Hagemann TM, Allen HC, Farmer K, Burton ME, Chavez-Bueno S, Johnson PN. Vancomycin Dosing and Pharmacokinetics in Postoperative Pediatric Cardiothoracic Surgery Patients. J Pediatr Pharmacol Ther. 2016 Jan-Feb; 21(1):66-74. PMID: 26997930.
      View in: PubMed
    13. Day MW, Jackson LA, Akins DR, Dyer DW, Chavez-Bueno S. Whole-Genome Sequences of the Archetypal K1 Escherichia coli Neonatal Isolate RS218 and Contemporary Neonatal Bacteremia Clinical Isolates SCB11, SCB12, and SCB15. Genome Announc. 2015 Feb 26; 3(1). PMID: 25720688.
      View in: PubMed
    14. Chavez-Bueno S, Day MW, Toby IT, Akins DR, Dyer DW. Genome Sequence of SCB34, a Sequence Type 131 Multidrug-Resistant Escherichia coli Isolate Causing Neonatal Early-Onset Sepsis. Genome Announc. 2014 Jun 12; 2(3). PMID: 24926049.
      View in: PubMed
    15. Shakir SM, Goldbeck JM, Robison D, Eckerd AM, Chavez-Bueno S. Genotypic and phenotypic characterization of invasive neonatal Escherichia coli clinical isolates. Am J Perinatol. 2014 Nov; 31(11):975-82. PMID: 24566757.
      View in: PubMed
    16. Miller M, Miller JL, Hagemann TM, Harrison D, Chavez-Bueno S, Johnson PN. Vancomycin dosage in overweight and obese children. Am J Health Syst Pharm. 2011 Nov 01; 68(21):2062-8. PMID: 22011985.
      View in: PubMed
    17. Chavez-Bueno S, Beasley JA, Goldbeck JM, Bright BC, Morton DJ, Whitby PW, Stull TL. 'Haptoglobin concentrations in preterm and term newborns'. J Perinatol. 2011 Jul; 31(7):500-3. PMID: 21252963.
      View in: PubMed
    18. Ch?vez-Bueno S, Stull TL. Pediatric vaccines on the horizon. Am J Med Sci. 2010 Sep; 340(3):226-31. PMID: 20697256.
      View in: PubMed
    19. Chavez-Bueno S, Stull TL. Antibacterial agents in pediatrics. Infect Dis Clin North Am. 2009 Dec; 23(4):865-80, viii. PMID: 19909888.
      View in: PubMed
    20. Mej?as A, Ch?vez-Bueno S, G?mez AM, Somers C, Estripeaut D, Torres JP, Jafri HS, Ramilo O. Respiratory syncytial virus persistence: evidence in the mouse model. Pediatr Infect Dis J. 2008 Oct; 27(10 Suppl):S60-2. PMID: 18820580.
      View in: PubMed
    21. Ch?vez-Bueno S, Mej?as A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J. 2007 Dec; 26(12):1089-93. PMID: 18043443.
      View in: PubMed
    22. Mej?as A, Ch?vez-Bueno S, Raynor MB, Connolly J, Kiener PA, Jafri HS, Ramilo O. Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model. Virol J. 2007 Oct 25; 4:109. PMID: 17961258.
      View in: PubMed
    23. Bogdanovich T, Aydin N, Chavez-Bueno S, McCracken G, Bozdogan B, Appelbaum PC. Genetic characterization of erythromycin- and methicillin-resistant community-acquired Staphylococcus aureus isolated from children in Texas. Diagn Microbiol Infect Dis. 2007 Oct; 59(2):231-3. PMID: 17662559.
      View in: PubMed
    24. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007 Apr 15; 195(8):1126-36. PMID: 17357048.
      View in: PubMed
    25. Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Murgu?a De Sierra T, Simoes EA, Shaha S, Welliver R. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect. 2007 Oct; 135(7):1077-90. PMID: 17346359.
      View in: PubMed
    26. Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, Gomez AM, Mejias A, Somers C, Chavez-Bueno S, McCracken GH, Hardy RD. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun. 2007 Jan; 75(1):236-42. PMID: 17074851.
      View in: PubMed
    27. Fonseca-Aten M, Okada PJ, Bowlware KL, Chavez-Bueno S, Mejias A, Rios AM, Katz K, Olsen K, Ng S, Jafri HS, McCracken GH, Ramilo O, Hardy RD. Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2006 Oct; 97(4):457-63. PMID: 17069099.
      View in: PubMed
    28. Fonseca-Aten M, Rios AM, Mejias A, Chavez-Bueno S, Katz K, Gomez AM, Ramilo O, McCracken GH, Hardy RD. Treatment of experimental chronic pulmonary mycoplasmosis. Int J Antimicrob Agents. 2006 Sep; 28(3):253-8. PMID: 16891098.
      View in: PubMed
    29. Ch?vez-Bueno S, Mej?as A, Welliver RC. Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis. Treat Respir Med. 2006; 5(6):483-94. PMID: 17154675.
      View in: PubMed
    30. Mej?as A, Ch?vez-Bueno S, Jafri HS, Ramilo O. Respiratory syncytial virus infections: old challenges and new opportunities. Pediatr Infect Dis J. 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PMID: 16378045.
      View in: PubMed
    31. Mej?as A, Ch?vez-Bueno S, R?os AM, Aten MF, Raynor B, Peromingo E, Soni P, Olsen KD, Kiener PA, G?mez AM, Jafri HS, Ramilo O. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. Antimicrob Agents Chemother. 2005 Nov; 49(11):4700-7. PMID: 16251314.
      View in: PubMed
    32. Fonseca-Aten M, Salvatore CM, Mej?as A, R?os AM, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Hardy RD. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2005 Oct; 49(10):4128-36. PMID: 16189089.
      View in: PubMed
    33. R?os AM, Fonseca-Aten M, Mej?as A, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Ramilo O, Hardy RD. Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2005 Sep; 49(9):3970-3. PMID: 16127085.
      View in: PubMed
    34. Mej?as A, Ch?vez-Bueno S, Ramilo O. Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness. Curr Opin Infect Dis. 2005 Jun; 18(3):199-204. PMID: 15864095.
      View in: PubMed
    35. Ch?vez-Bueno S, McCracken GH. Bacterial meningitis in children. Pediatr Clin North Am. 2005 Jun; 52(3):795-810, vii. PMID: 15925663.
      View in: PubMed
    36. Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, Ahmad N, McCracken GH, Appelbaum PC. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother. 2005 Jun; 49(6):2283-8. PMID: 15917522.
      View in: PubMed
    37. Ch?vez-Bueno S, Mej?as A, G?mez AM, Olsen KD, R?os AM, Fonseca-Aten M, Ramilo O, Jafri HS. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J. 2005 May 25; 2:46. PMID: 15916706.
      View in: PubMed
    38. Ch?vez-Bueno S, Mej?as A, Jafri HS, Ramilo O. Respiratory syncytial virus: old challenges and new approaches. Pediatr Ann. 2005 Jan; 34(1):62-8. PMID: 15693217.
      View in: PubMed
    39. Fonseca-Aten M, R?os AM, Mej?as A, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Hardy RD. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. Am J Respir Cell Mol Biol. 2005 Mar; 32(3):201-10. PMID: 15626776.
      View in: PubMed
    40. Mej?as A, Ch?vez-Bueno S, R?os AM, Fonseca-Aten M, G?mez AM, Jafri HS, Ramilo O. [Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention]. An Pediatr (Barc). 2004 Sep; 61(3):252-60. PMID: 15469810.
      View in: PubMed
    41. R?os AM, Mej?as A, Ch?vez-Bueno S, Fonseca-Aten M, Katz K, Hatfield J, G?mez AM, Jafri HS, McCracken GH, Ramilo O, Hardy RD. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Antimicrob Agents Chemother. 2004 Aug; 48(8):2897-904. PMID: 15273098.
      View in: PubMed
    42. Mej?as A, Ch?vez-Bueno S, R?os AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, Kapur P, G?mez AM, Jafri HS, Ramilo O. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother. 2004 May; 48(5):1811-22. PMID: 15105140.
      View in: PubMed
    43. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis. 2004 May 15; 189(10):1856-65. PMID: 15122522.
      View in: PubMed
    44. Mej?as A, Ch?vez-Bueno S, Ramilo O. Human metapneumovirus: a not so new virus. Pediatr Infect Dis J. 2004 Jan; 23(1):1-7; quiz 8-10. PMID: 14743038.
      View in: PubMed
    45. Hardy RD, Rios AM, Chavez-Bueno S, Jafri HS, Hatfield J, Rogers BB, McCracken GH, Ramilo O. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrob Agents Chemother. 2003 May; 47(5):1614-20. PMID: 12709330.
      View in: PubMed
    46. Mendoza-Alvarez H, Chavez-Bueno S, Alvarez-Gonzalez R. Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations. IUBMB Life. 2000 Aug; 50(2):145-9. PMID: 11185961.
      View in: PubMed
    Chavez-Bueno's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (222) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department